"Disease Progression" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The worsening of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis.
| Descriptor ID |
D018450
|
| MeSH Number(s) |
C23.550.291.656
|
| Concept/Terms |
Disease Progression- Disease Progression
- Disease Progressions
- Progression, Disease
- Progressions, Disease
|
Below are MeSH descriptors whose meaning is more general than "Disease Progression".
Below are MeSH descriptors whose meaning is more specific than "Disease Progression".
This graph shows the total number of publications written about "Disease Progression" by people in this website by year, and whether "Disease Progression" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 1999 | 0 | 4 | 4 |
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 2 | 2 |
| 2002 | 0 | 5 | 5 |
| 2003 | 0 | 2 | 2 |
| 2004 | 0 | 3 | 3 |
| 2005 | 0 | 6 | 6 |
| 2006 | 0 | 4 | 4 |
| 2007 | 0 | 3 | 3 |
| 2008 | 0 | 4 | 4 |
| 2009 | 0 | 8 | 8 |
| 2010 | 0 | 8 | 8 |
| 2011 | 1 | 9 | 10 |
| 2012 | 1 | 9 | 10 |
| 2013 | 1 | 12 | 13 |
| 2014 | 0 | 16 | 16 |
| 2015 | 0 | 24 | 24 |
| 2016 | 2 | 18 | 20 |
| 2017 | 0 | 10 | 10 |
| 2018 | 0 | 8 | 8 |
| 2019 | 1 | 8 | 9 |
| 2020 | 2 | 16 | 18 |
| 2021 | 2 | 6 | 8 |
| 2022 | 0 | 5 | 5 |
| 2023 | 0 | 3 | 3 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Disease Progression" by people in Profiles.
-
Genetic drivers of heterogeneity in type 2 diabetes pathophysiology. Nature. 2024 Mar; 627(8003):347-357.
-
CKD stage-specific utility of two equations for predicting 1-year risk of ESKD. PLoS One. 2023; 18(11):e0293293.
-
Proteomics of CKD progression in the chronic renal insufficiency cohort. Nat Commun. 2023 Oct 10; 14(1):6340.
-
Effect of Adopting the New Race-Free 2021 Chronic Kidney Disease Epidemiology Collaboration Estimated Glomerular Filtration Rate Creatinine Equation on Racial Differences in Kidney Disease Progression Among People With Human Immunodeficiency Virus: An Observational Study. Clin Infect Dis. 2023 02 08; 76(3):461-468.
-
The bidirectional association between diabetes and long-COVID-19 - A systematic review. Diabetes Res Clin Pract. 2023 Jan; 195:110202.
-
Early immune markers of clinical, virological, and immunological outcomes in patients with COVID-19: a multi-omics study. Elife. 2022 10 14; 11.
-
Post-acute sequelae of SARS-CoV-2 with clinical condition definitions and comparison in a matched cohort. Nat Commun. 2022 10 12; 13(1):5822.
-
Characteristics and Outcomes of Suspected Digoxin Toxicity and Immune Fab Treatment Over the Past Two Decades-2000-2020. Am J Cardiol. 2022 11 15; 183:129-136.
-
Loop and thiazide diuretic use and risk of chronic kidney disease progression: a multicentre observational cohort study. BMJ Open. 2022 01 31; 12(1):e048755.
-
Photoreceptor degeneration in ABCA4-associated retinopathy and its genetic correlates. JCI Insight. 2022 01 25; 7(2).